KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $16.2 billion.

  • Merck's Other Accumulated Expenses fell 213.43% to $16.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $16.2 billion, marking a year-over-year decrease of 213.43%. This contributed to the annual value of $15.7 billion for FY2024, which is 45.67% down from last year.
  • According to the latest figures from Q3 2025, Merck's Other Accumulated Expenses is $16.2 billion, which was down 213.43% from $14.5 billion recorded in Q2 2025.
  • In the past 5 years, Merck's Other Accumulated Expenses ranged from a high of $16.5 billion in Q3 2024 and a low of $11.9 billion during Q1 2021
  • Over the past 5 years, Merck's median Other Accumulated Expenses value was $14.2 billion (recorded in 2022), while the average stood at $14.2 billion.
  • As far as peak fluctuations go, Merck's Other Accumulated Expenses skyrocketed by 2159.11% in 2021, and later plummeted by 943.13% in 2025.
  • Quarter analysis of 5 years shows Merck's Other Accumulated Expenses stood at $13.9 billion in 2021, then grew by 2.16% to $14.2 billion in 2022, then grew by 11.35% to $15.8 billion in 2023, then decreased by 0.46% to $15.7 billion in 2024, then increased by 3.13% to $16.2 billion in 2025.
  • Its Other Accumulated Expenses was $16.2 billion in Q3 2025, compared to $14.5 billion in Q2 2025 and $12.8 billion in Q1 2025.